In Vitro Drug Resistance in Childhood Acute Lymphoblastic Leukemia in Relation to Age and Immunophenotype

[1]  R. Pieters,et al.  In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions , 1990 .

[2]  M. Borowitz.  Immunologic markers in childhood acute lymphoblastic leukemia. , 1990, Hematology/oncology clinics of North America.

[3]  R. Pieters,et al.  DRUG SENSITIVITY ASSAYS IN LEUKAEMIA AND LYMPHOMA , 1990, British journal of haematology.

[4]  T. Hongo,et al.  An in vitro chemosensitivity test for the screening of anti‐cancer drugs in childhood leukemia , 1990, Cancer.

[5]  M. Borowitz,et al.  Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1989, Blood.

[6]  C. Taylor,et al.  Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. , 1989, British Journal of Cancer.

[7]  I. Viano,et al.  In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non‐lymphocytic leukemia , 1989, Hematological oncology.

[8]  R. Pieters,et al.  Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. , 1989, British Journal of Cancer.

[9]  R. Pieters,et al.  Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. , 1988, Cancer letters.

[10]  Denis R. Miller,et al.  Childhood Acute Lymphoblastic Leukemia: 1. Biological Features and Their Use in Predicting Outcome of Treatment , 1988 .

[11]  M. Borowitz,et al.  Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study. , 1985, Cancer research.

[12]  H. Sather,et al.  Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Reaman,et al.  Acute lymphoblastic leukemia in childhood. , 1985, Pediatric clinics of North America.

[14]  C. Spurr,et al.  Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia. , 1985, Seminars in oncology.

[15]  M. Cooper,et al.  Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group study. , 1984, Blood.

[16]  C. Pui,et al.  Glucocorticoid receptors in childhood acute lymphocytic leukemia. , 1982, Cancer research.

[17]  M. Cooper,et al.  An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia. , 1981, Blood.

[18]  J. Peto,et al.  Immunologically Defined Subclasses of Acute Lymphoblastic Leukaemia in Children: their Relationship to Presentation Features and Prognosis , 1981, British journal of haematology.

[19]  S. Iacobelli,et al.  Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia. , 1980, Blood.

[20]  R. Gelber,et al.  Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. , 1980, Blood.

[21]  H. Gralnick,et al.  American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. , 1975, The American journal of medicine.

[22]  F. Behm,et al.  Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Pui,et al.  Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. , 1986, Leukemia research.

[24]  J. Harmon,et al.  Glucocorticoid receptors and glucocorticoid resistance in human leukemia in vivo and in vitro. , 1986, Advances in experimental medicine and biology.

[25]  F. Behm,et al.  Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in children. , 1986, Leukemia research.

[26]  J. Pullen,et al.  Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group review. , 1986, Medical and pediatric oncology.

[27]  A. Bleyer,et al.  Analysis of prognostic factors in acute lymphoblastic leukemia. , 1986, Medical and pediatric oncology.

[28]  L. Frankel,et al.  Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. , 1986, Blood.

[29]  C. Pui,et al.  The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. , 1984, Leukemia research.